In vitro activity of RO 19-5247 (T-2525) against intestinal pathogens, glucose non-fermentative gram-negative rods, Legionella and Serratia.
D015281:Cefmenoxime / Q000031:analogs & derivatives* / Q000494:pharmacology; D002443:Ceftriaxone / Q000494:pharmacology; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000302:isolation & purification / Q000472:pathogenicity; D006801:Humans; D007410:Intestinal Diseases / Q000382:microbiology*; D007875:Legionella / Q000187:drug effects* / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D012705:Serratia / Q000187:drug effects* / Q000302:isolation & purification
C049493:cefteram; D002443:Ceftriaxone; D015281:Cefmenoxime